A novel role of proline oxidase in HIV-1 envelope glycoprotein-induced neuronal autophagy

Journal of Biological Chemistry

Volumn 290, Issue 42, 2015, Pages 25439-25451

  Pandhare, Jui ^a,b,c   Dash, Sabyasachi ^a,b   Jones, Bobby ^a,b,c   Villalta, Fernando ^a,b,c   Dash, Chandravanu ^a,b,d  

^a Center for Health Research   (United States)

^b School of Graduate Studies and Research   (United States)

^c Department of Microbiology and Immunology ^*  (United States)

^d MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYLATION; CATALYST ACTIVITY; CELL DEATH; DIGITAL STORAGE; GLYCOPROTEINS; PLANTS (BOTANY);

CELLULAR RESPONSE; ENVELOPE GLYCOPROTEINS; LUCIFERASE REPORTER ASSAYS; MECHANISTIC STUDIES; NEUROBLASTOMA CELLS; NEUROLOGICAL DISORDERS; NEURONAL APOPTOSIS; REACTIVE OXYGEN SPECIES;

NEURONS;

BECLIN 1; GLYCOPROTEIN GP 120; PROLINE DEHYDROGENASE; PROTEIN P53; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; AUTOPHAGY; BRAIN NERVE CELL; CELL FUNCTION; CELL PROTECTION; CONTROLLED STUDY; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; ONCOGENE; POX GENE; PRIORITY JOURNAL; PROTEIN TARGETING; ENZYMOLOGY; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; MITOCHONDRION; NERVE CELL; OXIDATION REDUCTION REACTION; PHYSIOLOGY; TUMOR CELL LINE; UPREGULATION;

AUTOPHAGY; CELL LINE, TUMOR; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MITOCHONDRIA; NEURONS; OXIDATION-REDUCTION; PROLINE OXIDASE; REACTIVE OXYGEN SPECIES; UP-REGULATION;

EID: 84944398940     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.652776     Document Type: Article

References (82)

1. Adams, E., and Frank, L. (1980) Metabolism of proline and the hydroxyprolines. Annu. Rev. Biochem. 49, 1005-1061
2. Phang, J. M. (1985) The regulatory functions of proline and pyrroline-5-carboxylic acid. Curr. Top. Cell. Regul. 25, 91-132
3. Yeh, G. C., and Phang, J. M. (1988) Stimulation of phosphoribosyl pyrophosphate and purine nucleotide production by pyrroline 5-carboxylate in human erythrocytes. J. Biol. Chem. 263, 13083-13089
4. Donald, S. P., Sun, X. Y., Hu, C. A., Yu, J., Mei, J. M., Valle, D., and Phang, J. M. (2001) Proline oxidase, encoded by p53-induced gene-6, catalyzes the generation of proline-dependent reactive oxygen species. Cancer Res. 61, 1810-1815
5. Pandhare, J., Cooper, S. K., and Phang, J. M. (2006) Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor γ-dependent and -independent mechanisms. J. Biol. Chem. 281, 2044-2052
6. Holmström, K. M., and Finkel, T. (2014) Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat. Rev. Mol. Cell Biol. 15, 411-421
7. Finkel, T. (2011) Signal transduction by reactive oxygen species. J. Cell Biol. 194, 7-15
8. Phang, J. M., Donald, S. P., Pandhare, J., and Liu, Y. (2008) The metabolism of proline, a stress substrate, modulates carcinogenic pathways. Amino Acids 35, 681-690
9. Phang, J. M., Liu, W., Hancock, C., and Christian, K. J. (2012) The proline regulatory axis and cancer. Front. Oncol. 2, 60
10. Phang, J. M., Liu, W., and Zabirnyk, O. (2010) Proline metabolism and microenvironmental stress. Annu. Rev. Nutr. 30, 441-463
11. Zabirnyk, O., Liu, W., Khalil, S., Sharma, A., and Phang, J. M. (2010) Oxidized low-density lipoproteins upregulate proline oxidase to initiate ROS-dependent autophagy. Carcinogenesis 31, 446-454
12. Liu, W., and Phang, J. M. (2012) Proline dehydrogenase (oxidase), a mitochondrial tumor suppressor, and autophagy under the hypoxia microenvironment. Autophagy 8, 1407-1409
13. Gogos, J. A., Santha, M., Takacs, Z., Beck, K. D., Luine, V., Lucas, L. R., Nadler, J. V., and Karayiorgou, M. (1999) The gene encoding proline dehydrogenase modulates sensorimotor gating in mice. Nat. Genet. 21, 434-439
14. Fremeau, R. T., Jr., Caron, M. G., and Blakely, R. D. (1992) Molecular cloning and expression of a high affinity L-proline transporter expressed in putative glutamatergic pathways of rat brain. Neuron 8, 915-926
15. Renick, S. E., Kleven, D. T., Chan, J., Stenius, K., Milner, T. A., Pickel, V. M., and Fremeau, R. T., Jr. (1999) The mammalian brain high-affinity L-proline transporter is enriched preferentially in synaptic vesicles in a subpopulation of excitatory nerve terminals in rat forebrain. J. Neurosci. 19, 21-33
16. Cohen, S. M., and Nadler, J. V. (1997) Proline-induced potentiation of glutamate transmission. Brain Res. 761, 271-282
17. Paterlini, M., Zakharenko, S. S., Lai, W. S., Qin, J., Zhang, H., Mukai, J., Westphal, K. G., Olivier, B., Sulzer, D., Pavlidis, P., Siegelbaum, S. A., Karayiorgou, M., and Gogos, J. A. (2005) Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice. Nat. Neurosci. 8, 1586-1594
18. Liu, H., Abecasis, G. R., Heath, S. C., Knowles, A., Demars, S., Chen, Y. J., Roos, J. L., Rapoport, J. L., Gogos, J. A., and Karayiorgou, M. (2002) Genetic variation in the 22q11 locus and susceptibility to schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 99, 16859-16864
19. Liu, H., Heath, S. C., Sobin, C., Roos, J. L., Galke, B. L., Blundell, M. L., Lenane, M., Robertson, B., Wijsman, E. M., Rapoport, J. L., Gogos, J. A., and Karayiorgou, M. (2002) Genetic variation at the 22q11 PRODH2/ DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 99, 3717-3722
20. Jacquet, H., Demily, C., Houy, E., Hecketsweiler, B., Bou, J., Raux, G., Lerond, J., Allio, G., Haouzir, S., Tillaux, A., Bellegou, C., Fouldrin, G., Delamillieure, P., Ménard, J. F., Dollfus, S., D'Amato, T., Petit, M., Thibaut, F., Frébourg, T., and Campion, D. (2005) Hyperprolinemia is a risk factor for schizoaffective disorder. Mol. Psychiatry 10, 479-485
21. Roussos, P., Giakoumaki, S. G., and Bitsios, P. (2009) A risk PRODH haplotype affects sensorimotor gating, memory, schizotypy, and anxiety in healthy male subjects. Biol. Psychiatry 65, 1063-1070
22. van Spronsen, M., and Hoogenraad, C. C. (2010) Synapse pathology in psychiatric and neurologic disease. Curr. Neurol. Neurosci. Rep 10, 207-214
23. Wyse, A. T., and Netto, C. A. (2011) Behavioral and neurochemical effects of proline. Metab. Brain Dis 26, 159-172
24. Albright, A. V., Soldan, S. S., and González-Scarano, F. (2003) Pathogenesis of human immunodeficiency virus-induced neurological disease. J. Neurovirol. 9, 222-227
25. Vivithanaporn, P., Heo, G., Gamble, J., Krentz, H. B., Hoke, A., Gill, M. J., and Power, C. (2010) Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study. Neurology 75, 1150-1158
26. Joska, J. A., Gouse, H., Paul, R. H., Stein, D. J., and Flisher, A. J. (2010) Does highly active antiretroviral therapy improve neurocognitive function? A systematic review. J. Neurovirol. 16, 101-114
27. Valcour, V., Shikuma, C., Shiramizu, B., Watters, M., Poff, P., Selnes, O., Holck, P., Grove, J., and Sacktor, N. (2004) Higher frequency of dementia in older HIV-1 individuals: the Hawaii aging with HIV-1 cohort. Neurology 63, 822-827
28. McArthur, J. C., Steiner, J., Sacktor, N., and Nath, A. (2010) Human immunodeficiency virus-associated neurocognitive disorders: mind the gap. Ann. Neurol. 67, 699-714
29. Clifford, D. B. (2000) Human immunodeficiency virus-associated dementia. Arch. Neurol. 57, 321-324
30. Rao, V. R., Ruiz, A. P., and Prasad, V. R. (2014) Viral and cellular factors underlying neuropathogenesis in HIV-associated neurocognitive disorders (HAND). AIDS Res. Ther. 11, 13
31. Kaul, M., Garden, G. A., and Lipton, S. A. (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410, 988-994
32. Nath, A. (2002) Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J. Infect. Dis. 186, S193-S198
33. González-Scarano, F., and Martín-García, J. (2005) The neuropathogenesis of AIDS. Nat. Rev. Immunol. 5, 69-81
34. Mocchetti, I., Bachis, A., and Avdoshina, V. (2012) Neurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transport. Neurotox. Res. 21, 79-89
35. Acquas, E., Bachis, A., Nosheny, R. L., Cernak, I., and Mocchetti, I. (2004) Human immunodeficiency virus type 1 protein gp120 causes neuronal cell death in the rat brain by activating caspases. Neurotox. Res. 5, 605-615
36. Agrawal, L., Louboutin, J. P., Marusich, E., Reyes, B. A., Van Bockstaele, E. J., and Strayer, D. S. (2010) Dopaminergic neurotoxicity of HIV-1 gp120: reactive oxygen species as signaling intermediates. Brain Res 1306, 116-130
37. Steiner, J., Haughey, N., Li, W., Venkatesan, A., Anderson, C., Reid, R., Malpica, T., Pocernich, C., Butterfield, D. A., and Nath, A. (2006) Oxidative stress and therapeutic approaches in HIV dementia. Antioxid. Redox Signal. 8, 2089-2100
38. Hu, S., Sheng, W. S., Lokensgard, J. R., Peterson, P. K., and Rock, R. B. (2009) Preferential sensitivity of human dopaminergic neurons to gp120-induced oxidative damage. J. Neurovirol. 15, 401-410
39. Jana, A., and Pahan, K. (2004) Human immunodeficiency virus type 1 gp120 induces apoptosis in human primary neurons through redox-regulated activation of neutral sphingomyelinase. J. Neurosci. 24, 9531-9540
40. Louboutin, J. P., and Strayer, D. S. (2012) Blood-brain barrier abnormalities caused by HIV-1 gp120: mechanistic and therapeutic implications. ScientificWorldJournal 2012, 482575
41. Yang, Y., Yao, H., Lu, Y., Wang, C., and Buch, S. (2010) Cocaine potentiates astrocyte toxicity mediated by human immunodeficiency virus (HIV-1) protein gp120. PLoS ONE 5, e13427
42. Chen, G., Ke, Z., Xu, M., Liao, M., Wang, X., Qi, Y., Zhang, T., Frank, J. A., Bower, K. A., Shi, X., and Luo, J. (2012) Autophagy is a protective response to ethanol neurotoxicity. Autophagy 8, 1577-1589
43. Pandhare, J., Donald, S. P., Cooper, S. K., and Phang, J. M. (2009) Regulation and function of proline oxidase under nutrient stress. J. Cell. Biochem. 107, 759-768
44. Finkel, T. (2012) Signal transduction by mitochondrial oxidants. J. Biol. Chem. 287, 4434-4440
45. Circu, M. L., and Aw, T. Y. (2010) Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic. Biol. Med. 48, 749-762
46. Vermes, I., Haanen, C., and Reutelingsperger, C. (2000) Flow cytometry of apoptotic cell death. J. Immunol. Methods 243, 167-190
47. Tanida, I. (2011) Autophagy basics. Microbiol Immunol 55, 1-11
48. Tanida, I. (2011) Autophagosome formation and molecular mechanism of autophagy. Antioxid. Redox Signal. 14, 2201-2214
49. Lee, J., Giordano, S., and Zhang, J. (2012) Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem. J. 441, 523-540
50. He, C., and Klionsky, D. J. (2009) Regulation mechanisms and signaling pathways of autophagy. Annu. Rev. Genet. 43, 67-93
51. Liu, W., Glunde, K., Bhujwalla, Z. M., Raman, V., Sharma, A., and Phang, J. M. (2012) Proline oxidase promotes tumor cell survival in hypoxic tumor microenvironments. Cancer Res. 72, 3677-3686
52. Kimura, S., Fujita, N., Noda, T., and Yoshimori, T. (2009) Monitoring autophagy in mammalian cultured cells through the dynamics of LC3. Methods Enzymol. 452, 1-12
53. Ichimura, Y., Kominami, E., Tanaka, K., and Komatsu, M. (2008) Selective turnover of p62/A170/SQSTM1 by autophagy. Autophagy 4, 1063-1066
54. Vinod, V., Padmakrishnan, C. J., Vijayan, B., and Gopala, S. (2014) 'How can I halt thee?' The puzzles involved in autophagic inhibition. Pharmacol. Res. 82, 1-8
55. Jayadev, S., Yun, B., Nguyen, H., Yokoo, H., Morrison, R. S., and Garden, G. A. (2007) The glial response to CNS HIV infection includes p53 activation and increased expression of p53 target genes. J Neuroimmune Pharmacol. 2, 359-370
56. Khan, M. Z., Shimizu, S., Patel, J. P., Nelson, A., Le, M. T., Mullen-Przeworski, A., Brandimarti, R., Fatatis, A., and Meucci, O. (2005) Regulation of neuronal P53 activity by CXCR 4. Mol. Cell Neurosci. 30, 58-66
57. Garden, G. A., and Morrison, R. S. (2005) The multiple roles of p53 in the pathogenesis of HIV associated dementia. Biochem. Biophys. Res. Commun. 331, 799-809
58. Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., and Vogelstein, B. (1997) A model for p53-induced apoptosis. Nature 389, 300-305
59. Scherz-Shouval, R., Weidberg, H., Gonen, C., Wilder, S., Elazar, Z., and Oren, M. (2010) p53-dependent regulation of autophagy protein LC3 supports cancer cell survival under prolonged starvation. Proc. Natl. Acad. Sci. U.S.A. 107, 18511-18516
60. Castedo, M., Perfettini, J. L., Andreau, K., Roumier, T., Piacentini, M., and Kroemer, G. (2003) Mitochondrial apoptosis induced by the HIV-1 envelope. Ann. N.Y. Acad. Sci. 1010, 19-28
61. Meucci, O., Fatatis, A., Simen, A. A., Bushell, T. J., Gray, P. W., and Miller, R. J. (1998) Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 95, 14500-14505
62. Clift, I. C., Bamidele, A. O., Rodriguez-Ramirez, C., Kremer, K. N., and Hedin, K. E. (2014) β-Arrestin1 and distinct CXCR4 structures are required for stromal derived factor-1 to downregulate CXCR4 cell-surface levels in neuroblastoma. Mol. Pharmacol. 85, 542-552
63. Perfettini, J. L., Castedo, M., Roumier, T., Andreau, K., Nardacci, R., Piacentini, M., and Kroemer, G. (2005) Mechanisms of apoptosis induction by the HIV-1 envelope. Cell Death Differ. 12, 916-923
64. Castedo, M., Ferri, K. F., Blanco, J., Roumier, T., Larochette, N., Barretina, J., Amendola, A., Nardacci, R., Métivier, D., Este, J. A., Piacentini, M., and Kroemer, G. (2001) Human immunodeficiency virus 1 envelope glycoprotein complex-induced apoptosis involves mammalian target of rapamycin/FKBP12-rapamycin-associated protein-mediated p53 phosphorylation. J. Exp. Med. 194, 1097-1110
65. Bardi, G., Sengupta, R., Khan, M. Z., Patel, J. P., and Meucci, O. (2006) Human immunodeficiency virus gp120-induced apoptosis of human neuroblastoma cells in the absence of CXCR4 internalization. J. Neurovirol. 12, 211-218
66. Khan, M. Z., Brandimarti, R., Musser, B. J., Resue, D. M., Fatatis, A., and Meucci, O. (2003) The chemokine receptor CXCR4 regulates cell-cycle proteins in neurons. J. Neurovirol. 9, 300-314
67. De Clercq, E., Yamamoto, N., Pauwels, R., Balzarini, J., Witvrouw, M., De Vreese, K., Debyser, Z., Rosenwirth, B., Peichl, P., and Datema, R. (1994) Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100. Antimicrob. Agents Chemother. 38, 668-674
68. Bridger, G. J., Skerlj, R. T., Thornton, D., Padmanabhan, S., Martellucci, S. A., Henson, G. W., Abrams, M. J., Yamamoto, N., De Vreese, K., and Pauwels, R. (1995) Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-tetraazamacrocycles that inhibit HIV replication. Effects of macrocyclic ring size and substituents on the aromatic linker. J. Med. Chem. 38, 366-378
69. Hendrix, C. W., Flexner, C., MacFarland, R. T., Giandomenico, C., Fuchs, E. J., Redpath, E., Bridger, G., and Henson, G. W. (2000) Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob. Agents Chemother. 44, 1667-1673
70. Wan, Z. T., and Chen, X. L. (2010) Mechanisms of HIV envelope-induced T lymphocyte apoptosis. Virol. Sin. 25, 307-315
71. Twu, C., Liu, N. Q., Popik, W., Bukrinsky, M., Sayre, J., Roberts, J., Rania, S., Bramhandam, V., Roos, K. P., MacLellan, W. R., and Fiala, M. (2002) Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled pathways. Proc. Natl. Acad. Sci. U.S.A. 99, 14386-14391
72. Thomas, A. G., Bodner, A., Ghadge, G., Roos, R. P., and Slusher, B. S. (2009) GCP II inhibition rescues neurons from gp120IIIB-induced neurotoxicity. J. Neurovirol. 15, 449-457
73. Phang, J. M., Pandhare, J., and Liu, Y. (2008) The metabolism of proline as microenvironmental stress substrate. J. Nutr. 138, 2008S-2015S
74. Maxwell, S. A., and Davis, G. E. (2000) Differential gene expression in p53-mediated apoptosis-resistant vs. apoptosis-sensitive tumor cell lines. Proc. Natl. Acad. Sci. U.S.A. 97, 13009-13014
75. Li, L., Tan, J., Miao, Y., Lei, P., and Zhang, Q. (2015) ROS and autophagy: interactions and molecular regulatory mechanisms. Cell Mol Neurobiol. 35, 615-621
76. Azad, M. B., Chen, Y., and Gibson, S. B. (2009) Regulation of autophagy by reactive oxygen species (ROS): implications for cancer progression and treatment. Antioxid. Redox Signal. 11, 777-790
77. Lee, J. A. (2012) Neuronal autophagy: a housekeeper or a fighter in neuronal cell survival? Exp. Neurobiol. 21, 1-8
78. Xilouri, M., and Stefanis, L. (2010) Autophagy in the central nervous system: implications for neurodegenerative disorders. CNS Neurol. Disord. Drug Targets 9, 701-719
79. Yu, W. H., Cuervo, A. M., Kumar, A., Peterhoff, C. M., Schmidt, S. D., Lee, J. H., Mohan, P. S., Mercken, M., Farmery, M. R., Tjernberg, L. O., Jiang, Y., Duff, K., Uchiyama, Y., Näslund, J., Mathews, P. M., Cataldo, A. M., and Nixon, R. A. (2005) Macroautophagy-a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease. J. Cell Biol. 171, 87-98
80. Cherra, S. J., 3rd, and Chu, C. T. (2008) Autophagy in neuroprotection and neurodegeneration: A question of balance. Future Neurol. 3, 309-323
81. Zhou, D., Masliah, E., and Spector, S. A. (2011) Autophagy is increased in postmortem brains of persons with HIV-1-associated encephalitis. J. Infect. Dis. 203, 1647-1657
82. Espert, L., Denizot, M., Grimaldi, M., Robert-Hebmann, V., Gay, B., Varbanov, M., Codogno, P., and Biard-Piechaczyk, M. (2006) Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4. J. Clin. Invest. 116, 2161-2172